BR9006990A - Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo - Google Patents
Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodoInfo
- Publication number
- BR9006990A BR9006990A BR909006990A BR9006990A BR9006990A BR 9006990 A BR9006990 A BR 9006990A BR 909006990 A BR909006990 A BR 909006990A BR 9006990 A BR9006990 A BR 9006990A BR 9006990 A BR9006990 A BR 9006990A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- iodine
- treatment
- therapeutically
- elementary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Developing Agents For Electrophotography (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/292,968 US5171582A (en) | 1985-07-31 | 1989-01-03 | Treatment of iodine deficiency diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9006990A true BR9006990A (pt) | 1991-11-12 |
Family
ID=23127029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR909006990A BR9006990A (pt) | 1989-01-03 | 1990-01-03 | Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5171582A (pt) |
| EP (1) | EP0377266B1 (pt) |
| JP (1) | JP2994741B2 (pt) |
| AT (1) | ATE106738T1 (pt) |
| AU (1) | AU639222B2 (pt) |
| BR (1) | BR9006990A (pt) |
| CA (1) | CA1336889C (pt) |
| DE (1) | DE68915987T2 (pt) |
| DK (1) | DK128291A (pt) |
| ES (1) | ES2057098T3 (pt) |
| HU (1) | HUT57050A (pt) |
| MC (1) | MC2172A1 (pt) |
| WO (1) | WO1990007339A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589198A (en) * | 1985-07-31 | 1996-12-31 | 943038 Ontario, Inc. | Treatment of iodine deficiency diseases |
| US5250304A (en) * | 1985-07-31 | 1993-10-05 | Ghent William R | Treatment of iodine deficiency diseases |
| US6019970A (en) * | 1985-07-31 | 2000-02-01 | Ghent William R. | Treatment of iodine deficiency diseases |
| US5910318A (en) * | 1991-03-28 | 1999-06-08 | 943038 Ontario Inc. | Treatment of iodine deficiency diseases |
| US5955101A (en) * | 1991-03-28 | 1999-09-21 | 943038 Ontario Inc. | Dry starch-iodine pharmaceutical formulations |
| ES2114934T3 (es) * | 1991-03-28 | 1998-06-16 | Ontario Inc 943038 | Formulaciones farmaceuticas secas a base de almidon/yodo. |
| US5554600A (en) * | 1995-01-20 | 1996-09-10 | Eli Lilly And Company | Methods for inhibiting endometriosis |
| EP0722727A1 (en) * | 1995-01-20 | 1996-07-24 | Eli Lilly And Company | Benzofuran derivatives for inhibiting uterine fibroid disease |
| US5489587A (en) * | 1995-01-20 | 1996-02-06 | Eli Lilly And Company | Benzofurans used to inhibit bone loss |
| US6238644B1 (en) | 1997-09-03 | 2001-05-29 | Wayne State University | Method for treating and/or imaging breast cancer using radioactive iodide |
| US5885592A (en) * | 1997-10-29 | 1999-03-23 | Symbollon Corporation | Methods and pharmaceutical compositions for oral delivery of molecular iodine |
| AU2005274638A1 (en) * | 2004-08-20 | 2006-02-23 | Dennis Hardy O'dowd | Method of detecting and treating allogenic cells responsible for endometriosis |
| US9511151B2 (en) | 2010-11-12 | 2016-12-06 | Uti Limited Partnership | Compositions and methods for the prevention and treatment of cancer |
| US10988516B2 (en) | 2012-03-26 | 2021-04-27 | Uti Limited Partnership | Methods and compositions for treating inflammation |
| US9603948B2 (en) | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| MX2016005822A (es) | 2013-11-04 | 2016-12-02 | Uti Limited Partnership | Metodos y composiciones para inmunoterpia sostenida. |
| CA2984485A1 (en) | 2015-05-06 | 2016-12-15 | Uti Limited Partnership | Nanoparticle compositions for sustained therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4384960A (en) * | 1979-11-13 | 1983-05-24 | Polley R D | Iodine dispenser and method of dispensing iodine |
| US4816255A (en) * | 1985-07-31 | 1989-03-28 | Ghent William R | Treatment of iodine deficiency breast syndrome |
| FR2611733B1 (fr) * | 1987-02-26 | 1989-06-16 | Rhone Poulenc Chimie | Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux |
-
1989
- 1989-01-03 US US07/292,968 patent/US5171582A/en not_active Expired - Lifetime
- 1989-01-09 CA CA000587744A patent/CA1336889C/en not_active Expired - Fee Related
- 1989-01-10 ES ES89300194T patent/ES2057098T3/es not_active Expired - Lifetime
- 1989-01-10 AT AT89300194T patent/ATE106738T1/de not_active IP Right Cessation
- 1989-01-10 DE DE68915987T patent/DE68915987T2/de not_active Expired - Fee Related
- 1989-01-10 EP EP89300194A patent/EP0377266B1/en not_active Expired - Lifetime
-
1990
- 1990-01-03 AU AU48199/90A patent/AU639222B2/en not_active Ceased
- 1990-01-03 WO PCT/CA1990/000007 patent/WO1990007339A1/en active Application Filing
- 1990-01-03 BR BR909006990A patent/BR9006990A/pt not_active Application Discontinuation
- 1990-01-03 MC MC90@@D patent/MC2172A1/xx unknown
- 1990-01-03 HU HU90916A patent/HUT57050A/hu unknown
- 1990-01-03 JP JP2501437A patent/JP2994741B2/ja not_active Expired - Fee Related
-
1991
- 1991-07-01 DK DK128291A patent/DK128291A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK128291A (da) | 1991-08-21 |
| US5171582A (en) | 1992-12-15 |
| AU639222B2 (en) | 1993-07-22 |
| DE68915987D1 (de) | 1994-07-14 |
| HUT57050A (en) | 1991-11-28 |
| DK128291D0 (da) | 1991-07-01 |
| MC2172A1 (fr) | 1992-05-22 |
| EP0377266B1 (en) | 1994-06-08 |
| HU900916D0 (en) | 1991-10-28 |
| JP2994741B2 (ja) | 1999-12-27 |
| ES2057098T3 (es) | 1994-10-16 |
| EP0377266A1 (en) | 1990-07-11 |
| CA1336889C (en) | 1995-09-05 |
| JPH04503949A (ja) | 1992-07-16 |
| ATE106738T1 (de) | 1994-06-15 |
| WO1990007339A1 (en) | 1990-07-12 |
| AU4819990A (en) | 1990-08-01 |
| DE68915987T2 (de) | 1995-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9006990A (pt) | Composicao e dose diaria de iodo elementar para tratamento terapeutico de doenca provocada por deficiencia de iodo,processo de fabricar solucao aquosa pura de iodo elementar,processo e composicao para tratar terapeuticamente endometriose,processo e composicao para tratar profilaxia de cancer de mama,solucao aquosa de iodo elementar,composicao para tratar terapeuticamente cancer de mama,embalagem comercial e composicao para tratar terapeuticamente sindrome de mama provocada por deficiencia de iodo | |
| BG105588A (en) | Anthranilic acide amides and the use thereof as medicaments | |
| ES2060883T3 (es) | Procedimiento de obtencion del acido carnosico. | |
| EG18624A (en) | Process for preparing disinfecting compositions | |
| AP2088A (en) | Phenethanolamine derivatives for treatment of respiratory diseases | |
| IL156751A0 (en) | Substituted alkylamine derivatives and methods of use | |
| DE3370626D1 (en) | Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation | |
| AU1808488A (en) | Compounds for the treatment of alzheimer's disease | |
| EP0444196A4 (en) | Agent for treatment and prophylaxis of ischemic disease of heart or brain | |
| HUT61661A (en) | Process for producing pharmaceutical compositions for treating inflammatory gastrointestinal diseases | |
| ES2044514T3 (es) | Agua de aloe, procedimiento de preparacion y composiciones que la contienen. | |
| FI93117C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi | |
| CA2439879A1 (en) | C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses | |
| IT1169858B (it) | Complessi platino-diamminici, procedtimento per la loro prreparazione,procedimento per la preparazione di una compossizione medica contenente tali complessi platino-diamminici per il trattamento del cancro,nonche' composizione cosi' realizzata | |
| FR2651435B1 (pt) | ||
| DE3476392D1 (en) | Purine derivatives | |
| ES2075454T3 (es) | Forma cristalina pura de rifapentina. | |
| IE892094L (en) | New strontium salt, process for the preparation thereof and¹pharmaceutical compositions containing it | |
| IL111805A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of aphthae | |
| DE3371515D1 (en) | Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them | |
| GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
| EP0427190A3 (en) | Polyelectrolyte complexes for the treatment and the prophylaxis of viral diseases and process for their preparation | |
| GB2012163A (en) | Composition for treating diarrhoea | |
| JPS57203078A (en) | Citric acid naphthydrofuryl and therapeutical composition | |
| PT81003A (en) | Process for preparing novel benzodiazepinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |